CASI Pharmaceuticals appeared to be the Corporate Investor, which was created in 1991. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Rockville.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the CASI Pharmaceuticals, startups are often financed by Redhill Capital. The meaningful sponsors for the fund in investment in the same round are Panacea Venture, Dalton Venture.
Among the most popular portfolio startups of the fund, we may highlight Juventas. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The fund was created by John W Holaday.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019.
|Accord Ventures||Chiyoda, Japan|
|Alwin Capital||Beijing, Beijing, China|
|China Electronics Optics Valley Union Holding||China, Hubei, Wuhan|
|China Rundong Auto Group||China, Shanghai|
|CYBRiDGE||Japan, Yamanashi, Yamanashi Prefecture|
|Dorilton Capital||New York, New York, United States|
|Fujimori Kogyo||Japan, Tokyo|
|Galaxy Investment Partners||New York, New York, United States|
|H.I.G. Growth Partners||Florida, Miami, United States|
|Mercuria Investment||Chiyoda, Japan|
|Meridian Capital||Seattle, United States, Washington|
|Reflexion Capital||France, Ile-de-France, Paris|
|Senrigan Capital||China, Hong Kong, Hong Kong Island|
|Shenzhen Julin Touzi||China, Guangdong, Shenzhen|
|Tianrun Crankshaft||China, Shandong, Weihai|
|Youdao||Beijing, Beijing, China|
Precision Autoimmune Therapeutics
|$21M||08 Jul 2022||Beijing, Beijing, China|
|$15M||09 Jul 2019||Chaoyang City, Liaoning|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.